Full Text
PCV47 ROSUVASTATIN 40MG VERSUS ATORVASTATIN 80MG IN HIGH-RISK PATIENTS WITH HYPERCHOLESTEROLAEMIA- ECONOMIC ANALYSIS OF THE POLARIS STUDY

Abstract

Authors

PS Miller LA Leiter A Davies F Sosef

Back to Volume 8, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×